Biomedical Systems
Biomedical Systems · LumAIna™
LumAIna™. Bringing clarity to care.
Human understanding, clinical insight, and considered engineering. LumAIna™ brings these together to make the next step in care easier to understand.
Make the useful answer easier to reach.
Begin with the person.
Design around the questions, routines, and decisions people face when care becomes personal.
Make the next step clearer.
Turn complexity into an experience that supports patients, caregivers, and clinicians.
Build trust through evidence.
Let repeatability, clinical evidence, and real-world usability guide development.
LumAIna™ in practice
BiliBaby™: a development example.
A first example of the LumAIna™ approach: helping families navigate the delicate transition from newborn care in hospital to follow-up at home.
BiliBaby™ is being developed as an optical bilirubin monitoring system. A handheld experience and companion app are designed around one question: what should I do next?
A familiar routine
A handheld experience designed to fit into life with a newborn.
Context when it matters
A companion experience for setup, history, and caregiver-controlled sharing.
A deliberate evidence path
Engineering repeatability, clinical comparison, and lay-use validation guide the program.
BiliBaby™ is in development. Clinical accuracy has not been established; it is not a cleared medical device.
The moment that matters
More clarity for the first days at home.
Bringing a newborn home can bring joy and uncertainty at the same time. BiliBaby™ starts with the caregiver’s experience: a simple routine, understandable information, and a connection back to care when needed.
The intention is to support the family and their clinical team. Convenience must be earned through evidence, not assumed from a compelling design.
One connected experience
The device fits the routine.
The app keeps the context.
The proposed architecture keeps routine readings centered on the handheld device. The companion app supports setup, history, and sharing when useful.
That separation keeps the interaction focused while retaining the information a caregiver may want to discuss with their clinician.
The people behind this example
Clinical depth. Device execution.
Robert Stavis, PhD, MD
Chief Medical & Product Officer
Matthew Clemente
Chief Technology & Operations Officer
Gordon Y. Chang, MD
NICU Director · Coordinating PI
Janine Morris
Regulatory Affairs Advisor
George Stavis
General Counsel
Evidence before claims
A clear path from promise to proof.
Repeatability
Establish consistent engineering performance.
Clinical evidence
Compare performance through an appropriate clinical evidence program.
Real-world use
Validate the experience with the people who would use it.
Your next step
Help bring a clearer moment to care.
Explore BiliBaby™ as an example of LumAIna™’s biomedical development work. Request the investor overview and appropriate diligence materials, or introduce a relevant clinical or development partnership.
info@BiliBaby™.comBiomedical Systems
AIskera™
aiGlyph™ · Art that lives with you
Same skin. A deeper story.
An exploration of personal expression through glyphs: a beginning, a journey, an evolution, a focus, and what remains. The supplied concept imagines a visual story that changes over time.
In development. Not cleared or approved by the FDA. Not intended to diagnose, treat, cure or prevent any disease.
The illustrated timeline is a creative concept, not validated evidence of wear duration or skin performance.
AIskera™ · Machine concepts
Your next step
Artists: help shape the first glyph.
Interested in trying the concept and helping shape its creative possibilities? Share your practice, portfolio, and what you would like to explore.
clemente@themelioraworks.comContinue across Meliora